相关实验视频
Updated: Jun 14, 2025
14:57
Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
9.5K
基于Pyrazolone的Zn(II) 复合物在突变p53-携带癌细胞中显示抗瘤作用
Sonila Xhafa1, Corrado Di Nicola1, Alessia Tombesi2
1ChIP Research Center, School of Science and Technology, University of Camerino, via Madonna delle Carceri Camerino, 62032 Macerata, Italy.
Journal of medicinal chemistry
|September 2, 2024
概括
新的 (II) 复合物与皮拉龙希夫基显示抗癌活性. 细胞毒性与离子释放和癌细胞中突变p53蛋白水平的降低相关.
科学领域:
- 协调化学 协调化学
- 药用无机化学 药用无机化学
- 计算化学计算化学
背景情况:
- 来自pyrazolone连接体的希夫基是协调化学中的多功能构建块.
- (II) 复合物正在研究其潜在的生物活性,包括抗癌性质.
- 突变的p53蛋白经常与癌症的发展和进展有关.
研究的目的:
- 合成和表征新型的希夫基皮拉佐连接物及其 (II) 复合物.
- 研究这些金属复合物的结构,计算和光物理特性.
- 评估 (II) 综合体对表达特定突变p53蛋白的癌细胞系的体外抗癌活性.
主要方法:
- 合成和表征九个希夫基联体 (HL) 和它们的 (II) 复合物 ([Zn (L)) 2).
- 单晶X射线衍射用于选择复合物的结构确定.
- 密度功能理论 (DFT) 研究,粉末X射线衍射和光物理测量.
- 在体外细胞毒性测定和人类癌症细胞系中突变p53蛋白水平的评估.
主要成果:
- 已经成功合成了九个希夫基罗连接物及其相应的 (II) 复合物.
- 在研究的复合体中,X射线衍射揭示了围绕Zn (II) 离子的扭曲四面体几何形状.
- DFT研究阐明了电子性质,实验数据支持了对联体的解离-水解机制.
- 显著的细胞毒性活性和突变p53蛋白水平的降低被观察到复合体表现出更高的Zn{\displaystyle \Zn{\displaystyle \Zn{\displaystyle \Zn{\displaystyle \Zn}{\displaystyle \Zn}{\displaystyle \Zn}{\text{II}}}}) 离子释放.
结论:
- 合成的 (II) 复合物具有作为抗癌剂的潜力.
- 观察到的抗癌疗效与释放Zn(II) 离子和随后的突变p53.3的减少有关.
- 这些发现凸显了连接物解离和金属离子生物可用性在作用机制中的重要性.
相关概念视频
02:23Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
7.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.3K
02:56Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K